rss Posted May 6, 2021 Report Posted May 6, 2021 J Allergy Clin Immunol. 2021 May 3:S0091-6749(21)00721-1. doi: 10.1016/j.jaci.2021.03.049. Online ahead of print. ABSTRACT Cutaneous mast cells (MCs) express Mas-related G protein-coupled receptor-X2 (MRGPRX2; mouse ortholog MrgprB2), which is activated by an ever-increasing number of cationic ligands. Antimicrobial host defense peptides (HDPs) generated by keratinocytes contribute to host defense likely by two mechanisms; one involving direct killing of microbes and the other via MC activation through MRGPRX2. However, its inappropriate activation may cause pseudoallergy and likely contribute to the pathogenesis of rosacea, atopic dermatitis, allergic contact dermatitis, urticaria and mastocytosis. Gain- and loss-of-function missense single nucleotide polymorphisms in MRGPRX2 have been identified. The ability of certain ligands to serve as balanced or G protein-biased agonists have been defined. Small molecule HDP mimetics have been developed that display both direct antimicrobial activity and activate MCs via MRGPRX2. In addition, antibodies and reagents have been generated that modulate MRGPRX2 expression and signaling. In this article, we provide a comprehensive update on MrgprB2 and MRGPRX2 biology. We propose that harnessing MRGPRX2's host defense function by small molecule HDP mimetics may provide a novel approach for the treatment of antibiotic-resistant cutaneous infections. By contrast, MRGPRX2-specific antibodies and inhibitors could be utilized for the modulation of allergic and inflammatory diseases that are mediated via this receptor. PMID:33957166 | DOI:10.1016/j.jaci.2021.03.049 {url} = URL to article More information on Mast Cells and the Innate Immune System Disorder
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now